In diabetic patients, the observed risk of complications in the vascular system exceeds that expected from the classic risk factors, which are known also as metabolic syndrome. Experimental and clinical findings suggest that enhanced levels of free radicals found in Type 1 (insulin-dependent) as well as in Type 2 (non-insulin-dependent) diabetic patients could be the risk factor explaining the excess mortality observed in these individuals, E A. Gries (Diabetes-ResearchInstitute, Heinrich-Heine-University, D~isseldorf, Germany) stated. At a workshop held in Frankfurt am Main, a panel of international experts discussed the role of oxidative stress in the development of late diabetic complications and the implications for therapy.
ROS, if not trapped by antioxidants such as vitamin E and C, glutathione or lipoic acid (which also has metal chelating properties) cause peroxidation of membrane lipids and induce oxidation of LDL which are cytotoxic for the endothelium thus, for example, increasing the permeability of the endothelium. ROS mediate the reaction of aldehydes (from lipid peroxide degradion and from glucose autoxidation) with membrane proteins to advanced glycation end-products which are also toxic for the endothelium (Fig. 1) . Not only is the permeability of the endothelium by the action of ROS affected, the endothelial dependent vasorelaxation is also disturbed, characterised by a diminished nitric oxide (NO) and prostaglandin I release.
Furthermore, ROS can stimulate growth factors and induce the expression of adhesion molecules which are involved in the binding of platelets and monocytes to the endothelium. ROS also activate platelets with the release of platelet derived growth factor, thromboxane A2 and 5-hydroxytryptophan the latter two being potent vasoconstrictors and capable of inducing vasospasms if the endothelium is injured. ROS can also activate monocytes which release cytokines such as interleukin 1 and tumour necrosis factor which are both cytotoxic to the endothelial cells. These blood cells also release superoxide anions and thus reinforce oxidative stress. Treatment with antioxidants such as vitamin E can significantly reduce these deleterious effects of ROS, Roesen emphasized. Antioxidants have also proven to be effective in preventing oxidative damage and protein cross-linking in lens crystallines as Professor E. Elstner (Institute of Botanic and Microbiology, Munich, Germany) was able to demonstrate.
I
A new study conducted by Dr. B. Kuklinski (Klinikum Suedstadt, Rostock, Germany) confirms the association of Longterm diabetic complications with increased peroxidation and enhanced oxidative stress. As Dr. Kuklinski reported, 80 normoglycaemic patients were randomly assigned to receive either alpha-lipoic acid (Thioctacid| ASTA Medica AG, Frankfurt, Germany), D alpha-tocopherol, sodium selenite or no treatment. The patients who already suffered from at least two diabetic complications such as retinopathy, neuropathy and renal disease were treated for 12 weeks.
Antioxidant treatment reduced the peroxidation rate, characterized by malonic dialdehyde (MDA) levels which significantly differed from those in the control group. Associated with this decrease was a clear-cut improvement in vibratory sensibility-of the distal extremities. The temperature sensibility demonstrated significantly higher rates of improvement during antioxidative treatment compared with the control group. Higher rates of improvements and lower rates of deterioration were also seen in the Achilles tendon and patellar reflexes in the treatment group. The distal symmetric polyneuropathy improved rapidly (patient groups did not include severe cases with night-time pain at rest) which emphasizes, according to Dr. Kuklinski, the need to initiate antioxidant supplementation at an early stage of the disease.
With treatment the progression of retinal microangiopathy appeared to be halted. There was no improvement seen in the control group and sodium selenite while the highest rate of change was achieved in the group treated with alpha lipoic acid. Antioxidant treatment also substantially decreased proteinuria and albuminuria.
Under normal conditions the organisms intrinsic defense mechanisms against free radicals (which can originate from endogenous sources such as phagocytosis as well as from exogenous sources such as radiation, smoking or alcohol) are sufficient to prevent harm. This may not be the case when synthesis of free radicals is increased. In diabetes, enhanced oxidative stress can be due to two mechanisms. On the one hand, free radicals are generated in the process of glucose autoxidation. On the other hand, the impaired regeneration of natural protective antioxidants such as vitamin E, vitamin C, ghitathione and others is also a source of increased formation of free radicals. The regeneration of the reduced forms of these natural radical scavengers requires that NADPH be available in sufficient amounts. This may not be the case in diabetes since NADPH is consumed by the competing reduction of glucose to sorbitol in insulin-independent tissues under high glucose conditions. Antioxidants in biological systems are in a very delicate balance, as Professor L. Packer (University of California, Berkeley, Calif., USA) pointed out. Amongst the naturally occuring antioxidants, ubiquinols, vitamin E and carotenoids are the major lipophilic agents that protect membranes and lipoproteins. In the aqueous phase the major water soluble antioxidants are vitamin C and glutathione. Alpha-lipoic acid is normally bound in enzymes such as alpha-ketodehydrogenases, but it can also act as an antioxidant with amphiphilic properties. Prof. Packer added that the interaction of these free radical scavengers is a prerequisite for restoring the body's antioxidant capacity especially in the presence of enhanced free radical formation. This, however, requires sufficiently high concentrations of these antioxidants.
When vitamin E interacts with a lipid radical, the vitamin E itself forms a radical, as Professor Packer showed in human LDL suspensions. To prevent the depletion of vitamin E which is located in the periphery of LDL, the viamin E free radical can react with cellular reductants such as vitamin C (reduced ascorbic acid) which regenerates vitamin E.
A synergistic effect against the loss of vitamin E can be achieved by a combination of reduced lipoic acid (dihydrolipoic acid) and vitamin C. The observations indicate that dihydrolipoic acid can readily reduce oxidized vitamin C, Professor Packer concluded. This property of dihydrolipoic acid is due to its redox potential which is more negative than glutathione.
One, therefore, can expect that dihydrolipoic acid may even keep glutathione reduced but clearly reduces vitamin C, Professor Packer said.
There is another reason why patients with neuropathy may profit from treatment with lipoic acid. As Professor Packer explained, in diabetes glucose uptake into cells is impaired. This higher glucose also impairs uptake of dehydroascorbic acid (the oxidized form of vitamin C) which is taken up into the cell by th e same sugar transport system that is used by glucose. However, if lipoic acid is administered, both lipoic acid and dihydrolipoic acid become elevated since this antioxidant uses the fatty acid transport system which is not affected by glucose elevation in diabetes. Thus, the efficiency of the vitamin C and vitamin E cycles can be increased (Fig. 2) .
Oxidant radicals may also play a role in the initiation of Type 1 diabetes as Professor H.Kolb (Diabetes-Research-Institute, Heinrich-Heine University Dfisseldorf, Germany) outlined. In in vitro experiments, dihydrolipoic acid significantly inhibited macrophagemediated islet cell lysis while in the absence of this antioxidant an increase in NO-mediated islet cell lysis could be demonstrated. The results indicate that lipoic acid can obviously protect islet cells effectively from oxygen radical attack. 
